Open access · OA
via Europe PMC
Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers.
D'Aversa E, Grisafi M, Pernagallo S, Salvatori F, Singh AV, Nucciarone A, Tisato V, Gemmati D.
Frontiers in aging neuroscience · 2026
Abstract
Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder that represents the leading cause of dementia worldwide, affecting over 50 million people. This global burden is expected to rise dramatically over the coming decades because of global population aging, representing a public health concern. Despite significant advances in understanding AD pathophysiology, early diagnosis remains challenging, emphasizing the urgent need for novel, reliable diagnostic and predictive biomarkers capable of identifying individuals at risk of progression during the preclinical stages of the disease. Growing evidence indicates that epigenetics constitutes a dynamic interface through which aging and environmental exposures influence gene expression and cellular homeostasis, thereby contributing to AD susceptibility and progression. The present review summarizes current knowledge on the epigenetic landscape of AD, from canonical epigenetic mechanisms, including aberrant DNA methylation, histone modifications, and non-coding RNAs (ncRNAs), to the emerging role of mitoepigenetics and RNA methylation in disease-associated molecular mechanisms. Finally, we discuss the potential of epigenetic alterations as promising innovative biomarkers of AD, providing insights into novel avenues for diagnostic and therapeutic intervention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fnagi.2026.1959361
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
E, D., M, G., S, P., F, S., AV, S., A, N., V, T., & D., G. (2026). Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers. <em>Frontiers in aging neuroscience</em>. https://doi.org/10.3389/fnagi.2026.1959361
Vancouver
E D, M G, S P, F S, AV S, A N, et al. Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers. Frontiers in aging neuroscience. 2026. doi:10.3389/fnagi.2026.1959361.
BibTeX
@article{daversa2026Epigen,
title = {Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers.},
author = {D'Aversa E and Grisafi M and Pernagallo S and Salvatori F and Singh AV and Nucciarone A and Tisato V and Gemmati D.},
journal = {Frontiers in aging neuroscience},
year = {2026},
doi = {10.3389/fnagi.2026.1959361},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Lung 2026
Open access · OA
Impact of Epigenetic Modifications in Airway Diseases. Role of Inflammation, Environmental Factors and Aging.
Clinical Cosmetic and Investigational Dermatology 2025
Open access · CC-BY
Epigenetic Clocks in Skin Aging: From Exposome Drivers to Biomarkers and Therapeutic Interventions
Frontiers in physiology 2026
Open access · OA
Epigenetic signatures and cellular stress response pathways in metabolic dysfunction-associated steatotic liver disease: a personalized medicine perspective.
Climacteric : the journal of the International Menopause Society 2026
Citation only
Menopause and epigenetic changes: a review.
Cells 2024
Open access · CC-BY
Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
Journal of Parkinson s Disease 2023
Open access · CC-BY